NewGenIvf announces it has priced a public offering worth $1.25 million, selling shares at $0.07 per share, according to multiple outlets.
Both reports state the offering includes common shares and pre-funded warrants. The pre-funded warrants are included as part of the priced transaction, but the exact number of shares and warrants, as well as whether there are additional terms such as over-allotment options, are not detailed in the provided excerpts.
The coverage aligns on the same core terms—offer size and the per-share price—while differing only in emphasis. Investing.com frames the deal as a pricing announcement for the public offering, while Seeking Alpha highlights the inclusion of both shares and pre-funded warrants in its description of the priced transaction.
